Government of Saskatchewan ministries, Crown corporations and organizations are working to minimize the impacts of the postal service disruption.
Les ministères, les sociétés d’État et les organismes du gouvernement de la Saskatchewan travaillent à réduire au minimum les répercussions de l’interruption des services postaux.
Google Translate Disclaimer
A number of pages on the Government of Saskatchewan's website have been professionally translated in French. These translations are identified by a yellow box in the right or left rail that resembles the link below. The home page for French-language content on this site can be found at:
Where an official translation is not available, Google™ Translate can be used. Google™ Translate is a free online language translation service that can translate text and web pages into different languages. Translations are made available to increase access to Government of Saskatchewan content for populations whose first language is not English.
Software-based translations do not approach the fluency of a native speaker or possess the skill of a professional translator. The translation should not be considered exact, and may include incorrect or offensive language. The Government of Saskatchewan does not warrant the accuracy, reliability or timeliness of any information translated by this system. Some files or items cannot be translated, including graphs, photos and other file formats such as portable document formats (PDFs).
Any person or entities that rely on information obtained from the system does so at his or her own risk. Government of Saskatchewan is not responsible for any damage or issues that may possibly result from using translated website content. If you have any questions about Google™ Translate, please visit: Google™ Translate FAQs.
Released on April 5, 2011
Premier Greg Selinger and Premier Brad Wall announced today that Manitoba and Saskatchewan are working together to advance clinical trial research on the Multiple Sclerosis (MS) liberation therapy.
The Province of Manitoba will invest $5 million in MS research and follow the Saskatchewan Health Research Foundation (SHRF) protocols in a complementary research process in Manitoba. Saskatchewan was the first province to initiate clinical trials for the MS liberation procedure, when it announced a $5 million investment and launched a call for proposals in December 2010. SHRF is managing the publicly funded health research process, has developed a competitive call for clinical trials and appointed an expert advisory panel. A research proposal that will lead to clinical trials will be selected soon.
Today's $5 million funding announcement by the Province of Manitoba doubles the investment in clinical trials in Canada. The Manitoba Health Research Council (MHRC) will issue a call for proposals following consultations with the SHRF to ensure proposal criteria and review processes are complementary.
"MS patients and their families deserve to know as quickly as possible whether this experimental procedure is the breakthrough so many of us hope it is," Selinger said. "This partnership will help us get the answers we urgently need while providing Manitobans a chance to participate early in the clinical trial process."
"Saskatchewan is committed to advancing the science in MS diagnosis and treatment," Wall said. "We are pleased that Manitoba is proceeding with its own clinical trials, furthering efforts to get answers for people who suffer from this devastating disease."
The liberation procedure is a potentially ground-breaking discovery for the treatment of MS. However, it is not yet proven as a scientifically valid therapy. The funding announced today will help produce more extensive data and ultimately, may determine the procedure's validity as a treatment for MS.
Both SHRF and MHRC support the complementary approach. The multi-site clinical trial approach will strengthen the research conclusions by providing a larger sample size and the ability for research teams to pool results to further understand the effectiveness of the liberation procedure on MS patients.
"The MHRC understands that funding and progressing research in Multiple Sclerosis is vital to Canadians suffering with MS," MHRC Chair Dr. Brian Postl said. "We look forward to working with SHRF and welcome the opportunity to complement their process, as multi-site clinical trials are considered the gold standard of medical research because they provide the most conclusive evidence about the effectiveness of an experimental procedure."
"We will work very closely with MHRC to create complementary clinical trials that use common protocols and outcome measures," SHRF Chief Executive Officer June Bold said. "This approach will strengthen the scientific findings of the studies."
Patients in both provinces will have an opportunity to participate in the clinical trials once successful research teams have been announced. More information on research processes in Saskatchewan and Manitoba is available at www.shrf.ca and www.mhrc.mb.ca.
-30-
For more information, contact:
Kathy Young
Executive Council
Regina
Phone: 306-787-0425
June Bold
Saskatchewan Health Research Foundation
Saskatoon
Phone: 306-975-1680
Matt Williamson
Manitoba Cabinet Communications
Winnipeg
Phone: 204-945-1494
Kristen Hooper
Manitoba Health Research Council
Winnipeg
Phone: 204-775-1096
We need your feedback to improve saskatchewan.ca. Help us improve
